Tackling the challenge of cardiovascular diseases and diabetes across Europe: a joint action by more than 300 public health professionals. Commentary

Cardiovascular diseases (CVD) and diabetes pose significant health challenges in Europe, affecting millions and burdening healthcare systems. The recent EU4Health Programme places reducing the burden of non-communicable diseases (NCD) at the forefront, through a Joint Action focused on CVD and diabetes (JACARDI, Joint Action on CARdiovascular diseases and DIabetes). This initiative unites 21 European countries, including Ukraine, and over 300 experts. Employing an innovative approach and standardised methodology, JACARDI implements 142 pilot projects covering the entire "patient" journey. Particular focus will be given to improvement of data availability and quality. Additionally, JACARDI will emphasise transversal and intersectional aspects, such as health equity, determinants of health, and social, cultural, and ethnic diversity, while pioneering gender-transformative leadership. Committed to evidence-based interventions, JACARDI aims to harmonise strategies and disseminate knowledge for enhanced CVD and diabetes prevention and management. The goal is to identify effective strategies for wider implementation, fostering cross-national collaboration and fortifying Europe's health resilience.

Auteur(s) : Armocida Benedetta, Formenti Beatrice, Silano Marco, Aszalos Albert, Bueno Hector, El Yamani Mounia, Zabala Ane Fullaondo, Leonardi Matilde, Lindström Jaana, Michalak Karolina, Morillo Bernardino, Nowicki Michal, Oprešnik Denis, Palmieri Luigi, Papa Roberta, Peltonen Markku, Safadi Helena, Shchetynina Hanna, Skogberg Natalia, Tolonen Hanna, Wouters Edwin, Zaletel Jelka, Onder Graziano

Année de publication : 2024

Pages : 4-7

En relation avec

Nos dernières actualités

actualité

Enquête « Rapport au sexe » (ERAS) 2026 à destination des hommes ayant des...

actualité

Hervé Maisonneuve nommé référent à l’intégrité scientifique pour trois ans

Visuel illustratif

actualité

Baromètre de Santé publique France 2026 : lancement de l’enquête